mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.06 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.06 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.06 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |